Live Breaking News & Updates on California Inc

Stay updated with breaking news from California inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TD Cowen Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.50

TD Cowen Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.50
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Pacific Biosciences , Oene Mark Van , Davidw Meline , Securities Exchange Commission , Vanguard Group Inc , California Inc , Pricet Rowe Associates Inc , Capital International Investors , Goldman Sachs Group , Blackrock Inc , Investment Management , California Company Profile , Get Free Report , Director David , Exchange Commission , International Investors , Pricet Rowe Associates , California Company , California Daily ,

Pacific Biosciences of California (NASDAQ:PACB) Given New $2.50 Price Target at Sanford C. Bernstein

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price trimmed by Sanford C. Bernstein from $9.00 to $2.50 in a research note released on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on […] ....

United States , Sanfordc Bernstein , Davidw Meline , Oene Mark Van , Pacific Biosciences , Goldman Sachs Group , Qube Research Technologies Ltd , California Inc , Securities Exchange Commission , Moody Aldrich Partners , Investment Management , Free Report , California Price , Get Free Report , Director David , Exchange Commission , Investors Weigh In On Pacific Biosciences , Aldrich Partners , Technologies Ltd , California Daily , Pacific Biosciences Of California , Nasdaq Pacb , Lower Price Target ,

The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7.00

The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Oene Mark Van , Pacific Biosciences , Davidw Meline , Wolfe Research , Goldman Sachs Group , Investment Management , California Inc , Pricet Rowe Associates Inc , Blackrock Inc , Vanguard Group Inc , Securities Exchange Commission , Capital International Investors , Get Free Report , California Stock Down , Exchange Commission , Director David , International Investors , Pricet Rowe Associates , California Daily ,